Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics
Authors
Keywords
-
Journal
CURRENT OPINION IN CHEMICAL BIOLOGY
Volume 70, Issue -, Pages 102172
Publisher
Elsevier BV
Online
2022-07-02
DOI
10.1016/j.cbpa.2022.102172
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters
- (2022) Lei Li et al. VACCINE
- Therapeutic vaccination targeting CD40 and TLR3 controls melanoma growth through existing intratumoral CD8 T cells without new T cell infiltration
- (2021) Aaron D. Stevens et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synthetic protein conjugate vaccines provide protection against Mycobacterium tuberculosis in mice
- (2021) Cameron C. Hanna et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prolonged Codelivery of Hemagglutinin and a TLR7/8 Agonist in a Supramolecular Polymer–Nanoparticle Hydrogel Enhances Potency and Breadth of Influenza Vaccination
- (2021) Gillie A. Roth et al. ACS Biomaterials-Science & Engineering
- An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein
- (2021) Lucie Jelínková et al. npj Vaccines
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- Cord Blood-Based Approach to Assess Candidate Vaccine Adjuvants Designed for Neonates and Infants
- (2021) Daisuke Tokuhara et al. Vaccines
- Inclusion of an Optimized Plasmodium falciparum Merozoite Surface Protein 2–Based Antigen in a Trivalent, Multistage Malaria Vaccine
- (2021) Jacqueline S. Eacret et al. JOURNAL OF IMMUNOLOGY
- Enhanced Antitumor Immune Responses via a Self-Assembled Carrier-Free Nanovaccine
- (2021) Dan Liu et al. NANO LETTERS
- Emerging concepts in the science of vaccine adjuvants
- (2021) Bali Pulendran et al. NATURE REVIEWS DRUG DISCOVERY
- Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response
- (2021) Pierre Rosenbaum et al. Frontiers in Immunology
- The Effect of a TLR4 Agonist/Cationic Liposome Adjuvant on Varicella-Zoster Virus Glycoprotein E Vaccine Efficacy: Antigen Presentation, Uptake, and Delivery to Lymph Nodes
- (2021) Seo Ri Wui et al. Pharmaceutics
- Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines
- (2021) Yoshikazu Honda-Okubo et al. Pathogens
- Evolution of Toll-like receptor 7/8 agonist therapeutics and their delivery approaches: From antiviral formulations to vaccine adjuvants
- (2021) Sachin Bhagchandani et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection
- (2021) Lei Li et al. VACCINE
- A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization
- (2021) Isaac G. Sakala et al. VACCINE
- A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection
- (2021) Staffan Görander et al. VACCINE
- Deimmunization of flagellin for repeated administration as a vaccine adjuvant
- (2021) Koemchhoy Khim et al. npj Vaccines
- Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
- (2021) Laura T. Gray et al. BIOMATERIALS
- Systemic antiviral immunization by virus-mimicking nanoparticles-decorated erythrocytes
- (2021) Lu Wang et al. Nano Today
- Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective
- (2021) Jeremy Baldwin et al. Bioanalysis
- Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients
- (2020) Yingying Dou et al. ANTIVIRAL RESEARCH
- Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and β-glucan
- (2020) Rhoda Namakula et al. PLoS One
- Injectable dual-scale mesoporous silica cancer vaccine enabling efficient delivery of antigen/adjuvant-loaded nanoparticles to dendritic cells recruited in local macroporous scaffold
- (2020) Thanh Loc Nguyen et al. BIOMATERIALS
- Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein–Fusion Combination Vaccine
- (2020) Zhenghui Xu et al. ACS Infectious Diseases
- Controlling timing and location in vaccines
- (2020) Darrell J. Irvine et al. ADVANCED DRUG DELIVERY REVIEWS
- Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface
- (2020) Yiwen Zhao et al. BIOMATERIALS
- A TLR9-adjuvanted vaccine formulated into dissolvable microneedle patches or cationic liposomes protects against leishmaniasis after skin or subcutaneous immunization
- (2020) Juliane S. Lanza et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- VaxiPatch™, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017
- (2020) Thomas J. Ellison et al. VACCINE
- The TLR9 ligand CpG ODN 2006 is a poor adjuvant for the induction of de novo CD8+ T-cell responses in vitro
- (2020) Laura Papagno et al. Scientific Reports
- A Novel Synthetic Dual Agonistic Liposomal TLR4/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity
- (2020) Fumi Sato-Kaneko et al. Frontiers in Immunology
- New chimeric TLR7/NOD2 agonist is a potent adjuvant to induce mucosal immune responses
- (2020) Alice Gutjahr et al. EBioMedicine
- Self-Adjuvanting Cancer Vaccines from Conjugation-Ready Lipid A Analogues and Synthetic Long Peptides
- (2020) Niels R. M. Reintjens et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
- (2020) Ling Hao et al. Frontiers in Immunology
- Artificial intelligence and COVID-19: A multidisciplinary approach
- (2020) Abhimanyu S. Ahuja et al. Integrative Medicine Research
- Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
- (2020) Athina Zacharia et al. VACCINE
- Structural Basis of TLR2/TLR1 Activation by the Synthetic Agonist Diprovocim
- (2019) Lijing Su et al. JOURNAL OF MEDICINAL CHEMISTRY
- Glucopyranosyl lipid adjuvant enhances immune response to Ebola virus-like particle vaccine in mice
- (2019) Melek M.E. Sunay et al. VACCINE
- Triggering of Toll-like Receptors in Old Individuals. Relevance for Vaccination
- (2019) Nahid Zareian et al. CURRENT PHARMACEUTICAL DESIGN
- TLR agonist combinations that stimulate Th type I polarizing responses from human neonates
- (2018) Naveen Surendran et al. Innate Immunity
- The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells
- (2018) Marlena M. Westcott et al. VACCINE
- A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model
- (2018) Johannes Falke et al. WORLD JOURNAL OF UROLOGY
- Structure-based discovery of a specific TLR1–TLR2 small molecule agonist from the ZINC drug library database
- (2018) Zhipeng Chen et al. CHEMICAL COMMUNICATIONS
- Recent clinical trends in Toll-like receptor targeting therapeutics
- (2018) Muhammad Ayaz Anwar et al. MEDICINAL RESEARCH REVIEWS
- Identification of Human Toll-like Receptor 2-Agonistic Activity in Dihydropyridine–Quinolone Carboxamides
- (2018) Ziwei Hu et al. ACS Medicinal Chemistry Letters
- Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses
- (2017) Ranjna Madan-Lala et al. Scientific Reports
- Incorporation of Phosphonate into Benzonaphthyridine Toll-like Receptor 7 Agonists for Adsorption to Aluminum Hydroxide
- (2016) Alex Cortez et al. JOURNAL OF MEDICINAL CHEMISTRY
- The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models
- (2016) Alice Halliday et al. Parasites & Vectors
- TLR4 and TLR7/8 Adjuvant Combinations Generate Different Vaccine Antigen-Specific Immune Outcomes in Minipigs when Administered via the ID or IN Routes
- (2016) Paul F. McKay et al. PLoS One
- The rLrp of Mycobacterium tuberculosis inhibits proinflammatory cytokine production and downregulates APC function in mouse macrophages via a TLR2-mediated PI3K/Akt pathway activation-dependent mechanism
- (2015) Yuan Liu et al. Cellular & Molecular Immunology
- Zymosan Induces Immune Responses Comparable with Those of Adults in Monocytes, Dendritic Cells, and Monocyte-Derived Dendritic Cells from Cord Blood
- (2015) Kyoko Nohmi et al. JOURNAL OF PEDIATRICS
- In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity
- (2015) Geoffrey M Lynn et al. NATURE BIOTECHNOLOGY
- Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
- (2015) Misako Matsumoto et al. Nature Communications
- Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells
- (2015) S. Van Lint et al. Cancer Immunology Research
- Structural Relationship of the Lipid A Acyl Groups to Activation of Murine Toll-Like Receptor 4 by Lipopolysaccharides from Pathogenic Strains of Burkholderia mallei, Acinetobacter baumannii, and Pseudomonas aeruginosa
- (2015) Kirill V. Korneev et al. Frontiers in Immunology
- TLR Cross-talk Confers Specificity to Innate Immunity
- (2014) Rebecca S. T. Tan et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- A Comparative Review of Toll-Like Receptor 4 Expression and Functionality in Different Animal Species
- (2014) Céline Vaure et al. Frontiers in Immunology
- Identification of Substituted Pyrimido[5,4-b]indoles as Selective Toll-Like Receptor 4 Ligands
- (2013) Michael Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
- (2012) Tobias R. Kollmann et al. IMMUNITY
- Contribution of Toll-like receptor signaling to germinal center antibody responses
- (2012) Anthony L. DeFranco et al. IMMUNOLOGICAL REVIEWS
- BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-κB pathway
- (2012) Egest J. Pone et al. Nature Communications
- Mice, men and the relatives: cross-species studies underpin innate immunity
- (2012) C. E. Bryant et al. Open Biology
- CpG DNA as a vaccine adjuvant
- (2011) Christian Bode et al. Expert Review of Vaccines
- CCR7 Essentially Contributes to the Homing of Plasmacytoid Dendritic Cells to Lymph Nodes under Steady-State As Well As Inflammatory Conditions
- (2011) S. Seth et al. JOURNAL OF IMMUNOLOGY
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- Toll-Like Receptor Agonists Synergize with CD40L to Induce Either Proliferation or Plasma Cell Differentiation of Mouse B Cells
- (2011) Emmanuelle Boeglin et al. PLoS One
- Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO®) induced neutralizing antibody titers
- (2011) Yvonne Van Gessel et al. VACCINE
- Vaccine adjuvant activity of 3M-052: An imidazoquinoline designed for local activity without systemic cytokine induction
- (2011) Dmitri Smirnov et al. VACCINE
- Dysregulation of human Toll-like receptor function in aging
- (2010) Albert C. Shaw et al. AGEING RESEARCH REVIEWS
- Toll-Like Receptor Agonists
- (2010) Sacha Gnjatic et al. CANCER JOURNAL
- Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenza
- (2010) Jonathan P Wong et al. Expert Review of Respiratory Medicine
- Mal connects TLR2 to PI3Kinase activation and phagocyte polarization
- (2009) S Santos-Sierra et al. EMBO JOURNAL
- TLR2 engagement on memory CD8+T cells improves their cytokine-mediated proliferation and IFN-γ secretion in the absence of Ag
- (2009) Anne Cottalorda et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Toll-like receptors - sentries in the B-cell response
- (2009) Isabelle Bekeredjian-Ding et al. IMMUNOLOGY
- TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones
- (2009) Il-Young Hwang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Engagement of TLR2 Does not Reverse the Suppressor Function of Mouse Regulatory T Cells, but Promotes Their Survival
- (2009) Q. Chen et al. JOURNAL OF IMMUNOLOGY
- TLR9 as a key receptor for the recognition of DNA☆
- (2008) Y KUMAGAI et al. ADVANCED DRUG DELIVERY REVIEWS
- A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection
- (2008) M. Quigley et al. BLOOD
- The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype
- (2008) M E A Borm et al. GENES AND IMMUNITY
- TLR2 – promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity
- (2008) Ulrich Zähringer et al. IMMUNOBIOLOGY
- Immunization with a Toll-Like Receptor 7 and/or 8 Agonist Vaccine Adjuvant Increases Protective Immunity against Leishmania major in BALB/c Mice
- (2008) W.-W. Zhang et al. INFECTION AND IMMUNITY
- Enhancing the T-cell Stimulatory Capacity of Human Dendritic Cells by Co-electroporation With CD40L, CD70 and Constitutively Active TLR4 Encoding mRNA
- (2008) Aude Bonehill et al. MOLECULAR THERAPY
- TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β
- (2008) Jonathan C Kagan et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started